High-Dose versus Standard-Dose Tigecycline Treatment of Secondary Bloodstream Infections Caused by Extensively Drug-Resistant Acinetobacter baumannii: An Observational Cohort Study

High-Dose versus Standard-Dose Tigecycline Treatment of Secondary Bloodstream Infections Caused by Extensively Drug-Resistant Acinetobacter baumannii: An Observational Cohort Study

Hui Han,1,* Weidong Qin,1,* Yue Zheng,2– 5 Dongming Cao,6 Haining Lu,7 Lu Zhang,8 Yi Cui,1 Yuanyuan Hu,1 Wei Li,9 Haipeng Guo,1 Dawei Wu,7 Chen Li,1 Hao Wang,1,2,10 Yuguo Chen2– 5 1Department of Critical Care Medicine, Qilu Hospital of Shandong University, Jinan, People’s Republic of...

Full description

Bibliographic Details
Main Authors: Han H, Qin W, Zheng Y, Cao D, Lu H, Zhang L, Cui Y, Hu Y, Li W, Guo H, Wu D, Li C, Wang H, Chen Y
Format: Article
Language:English
Published: Dove Medical Press 2021-09-01
Series:Infection and Drug Resistance
Subjects:
acinetobacter baumannii
bloodstream infection
extensively drug-resistant
tigecycline
high-dose
Online Access:https://www.dovepress.com/high-dose-versus-standard-dose-tigecycline-treatment-of-secondary-bloo-peer-reviewed-fulltext-article-IDR

Internet

https://www.dovepress.com/high-dose-versus-standard-dose-tigecycline-treatment-of-secondary-bloo-peer-reviewed-fulltext-article-IDR

Similar Items